美麗田園醫療健康(02373.HK)7月14日購回3萬股公司股份
格隆匯7月14日丨美麗田園醫療健康(02373.HK)公告,公司於2025年7月14日於市場購回3萬股公司股份,總交易金額約88.5萬港元,交易平均價約每股29.50港元。自2025年7月10日至本公告日,公司累計購回9.05萬股公司股份,累計交易金額約264.7萬港元。
目前的股份成交價並不反映股份的內在價值和公司的實際業務前景。董事會相信,股份購回體現了管理層對企業長期價值的堅定信心,有利於提升集團資本市場價值及股東回報能力。本次股份購回符合公司及其股東的整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.